The Immunomodulatory Effects of Mesenchymal Stem Cell Polarization Within the Tumor Microenvironment Niche

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2017 Nov 29

PMID 29181035

Citations 55

Authors

Cosette M Rivera-Cruz

Joseph J Shearer

Manoel Figueiredo Neto

Marxa L Figueiredo

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSCs) represent a promising tool for cell therapy, particularly for their antitumor effects. This cell population can be isolated from multiple tissue sources and also display an innate ability to home to areas of inflammation, such as tumors. Upon entry into the tumor microenvironment niche, MSCs promote or inhibit tumor progression by various mechanisms, largely through the release of soluble factors. These factors can be immunomodulatory by activating or inhibiting both the adaptive and innate immune responses. The mechanisms by which MSCs modulate the immune response are not well understood. Because of this, the relationship between MSCs and immune cells within the tumor microenvironment niche continues to be an active area of research in order to help explain the apparent contradictory findings currently available in the literature. The ongoing research aims to enhance the potential of MSCs in future therapeutic applications.

Citing Articles

Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond.

Yarahmadi A, Dorri Giv M, Hosseininejad R, Rezaie A, Mohammadi N, Afkhami H Front Neurol. 2025; 16:1472679.

PMID: 39974358 PMC: 11835705. DOI: 10.3389/fneur.2025.1472679.

Therapeutic potential and mechanisms of stem cells in major depressive disorder: a comprehensive review.

Li J, Wang Y, Zhang Y, Liu M, Rong X, Jiang J Front Pharmacol. 2024; 15:1476558.

PMID: 39654612 PMC: 11625547. DOI: 10.3389/fphar.2024.1476558.

Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists.

Minev T, Balbuena S, Gill J, Marincola F, Kesari S, Lin F Oncotarget. 2024; 15:793-805.

PMID: 39576660 PMC: 11584032. DOI: 10.18632/oncotarget.28672.

Harnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment.

Kangari P, Salahlou R, Vandghanooni S Adv Pharm Bull. 2024; 14(3):574-590.

PMID: 39494266 PMC: 11530882. DOI: 10.34172/apb.2024.052.

Hypoxic Stress Induces Complement-Mediated Lysis of Mesenchymal Stem Cells by Downregulating Factor H and CD59.

Khaswaneh R, Abu-El-Rub E, Alzubi A, Almahasneh F, Almazari R, Ai-Jariri H Tissue Eng Regen Med. 2024; 22(1):105-112.

PMID: 39485618 PMC: 11711716. DOI: 10.1007/s13770-024-00678-6.

References

Hall S, Tsoyi K, Ith B, Padera Jr R, Lederer J, Wang Z . Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils. Stem Cells. 2012; 31(2):397-407. PMC: 3572335. DOI: 10.1002/stem.1270. View

Fisher D, Appenheimer M, Evans S . The two faces of IL-6 in the tumor microenvironment. Semin Immunol. 2014; 26(1):38-47. PMC: 3970580. DOI: 10.1016/j.smim.2014.01.008. View

Fotia C, Massa A, Boriani F, Baldini N, Granchi D . Prolonged exposure to hypoxic milieu improves the osteogenic potential of adipose derived stem cells. J Cell Biochem. 2015; 116(7):1442-53. DOI: 10.1002/jcb.25106. View

Zheng H, Zou W, Shen J, Xu L, Wang S, Fu Y . Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth. Stem Cells Transl Med. 2016; 5(9):1216-28. PMC: 4996440. DOI: 10.5966/sctm.2015-0300. View

Eisenbacher J, Schrezenmeier H, Jahrsdorfer B, Kaltenmeier C, Rojewski M, Yildiz T . S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10+/IDO+ lymphocytes. J Immunol. 2014; 192(12):6102-10. DOI: 10.4049/jimmunol.1303144. View

Lakatos K, Kalomoiris S, Merkely B, Nolta J, Fierro F . Mesenchymal Stem Cells Respond to Hypoxia by Increasing Diacylglycerols. J Cell Biochem. 2015; 117(2):300-7. PMC: 10695329. DOI: 10.1002/jcb.25292. View

Zolochevska O, Yu G, Gimble J, Figueiredo M . Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth. Stem Cells Dev. 2011; 21(7):1112-23. DOI: 10.1089/scd.2011.0247. View

Casazza A, Di Conza G, Wenes M, Finisguerra V, Deschoemaeker S, Mazzone M . Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. Oncogene. 2013; 33(14):1743-54. DOI: 10.1038/onc.2013.121. View

Abomaray F, Al Jumah M, Kalionis B, Alaskar A, Al Harthy S, Jawdat D . Human Chorionic Villous Mesenchymal Stem Cells Modify the Functions of Human Dendritic Cells, and Induce an Anti-Inflammatory Phenotype in CD1+ Dendritic Cells. Stem Cell Rev Rep. 2014; 11(3):423-41. DOI: 10.1007/s12015-014-9562-8. View

10.

Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D . The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell Immunol. 2011; 270(2):207-16. DOI: 10.1016/j.cellimm.2011.05.010. View

11.

Fotia C, Massa A, Boriani F, Baldini N, Granchi D . Hypoxia enhances proliferation and stemness of human adipose-derived mesenchymal stem cells. Cytotechnology. 2014; 67(6):1073-84. PMC: 4628915. DOI: 10.1007/s10616-014-9731-2. View

12.

Waterman R, Tomchuck S, Henkle S, Betancourt A . A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One. 2010; 5(4):e10088. PMC: 2859930. DOI: 10.1371/journal.pone.0010088. View

13.

Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A . Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One. 2012; 7(2):e30563. PMC: 3282707. DOI: 10.1371/journal.pone.0030563. View

14.

Buravkova L, Andreeva E, Gogvadze V, Zhivotovsky B . Mesenchymal stem cells and hypoxia: where are we?. Mitochondrion. 2014; 19 Pt A:105-12. DOI: 10.1016/j.mito.2014.07.005. View

15.

Ejtehadifar M, Shamsasenjan K, Movassaghpour A, Akbarzadehlaleh P, Dehdilani N, Abbasi P . The Effect of Hypoxia on Mesenchymal Stem Cell Biology. Adv Pharm Bull. 2015; 5(2):141-9. PMC: 4517092. DOI: 10.15171/apb.2015.021. View

16.

Waterman R, Morgenweck J, Nossaman B, Scandurro A, Scandurro S, Betancourt A . Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy. Stem Cells Transl Med. 2012; 1(7):557-65. PMC: 3659725. DOI: 10.5966/sctm.2012-0025. View

17.

Liu W, Liu J, Wu J, Zhang L, Liu F, Yin L . Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway. PLoS One. 2013; 8(1):e55487. PMC: 3559548. DOI: 10.1371/journal.pone.0055487. View

18.

Bahrambeigi V, Ahmadi N, Moisyadi S, Urschitz J, Salehi R, Javanmard S . PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma. Mol Cancer. 2014; 13:255. PMC: 4258801. DOI: 10.1186/1476-4598-13-255. View

19.

Hung S, Ho J, Shih Y, Lo T, Lee O . Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. J Orthop Res. 2011; 30(2):260-6. DOI: 10.1002/jor.21517. View

20.

Zimmerlin L, Donnenberg A, Rubin J, Basse P, Landreneau R, Donnenberg V . Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A. 2010; 17(1-2):93-106. PMC: 3011910. DOI: 10.1089/ten.TEA.2010.0248. View